Substantial improvement in a Meige's syndrome patient with levetiracetam treatment

Theresa A Zesiewicz; Elan D Louis; Kelly L Sullivan; Martin Menkin; Peter B Dunne; Robert A Hauser

doi:10.1002/mds.20233

Substantial improvement in a Meige's syndrome patient with levetiracetam treatment

Mov Disord. 2004 Dec;19(12):1518-21. doi: 10.1002/mds.20233.

Authors

Theresa A Zesiewicz¹, Elan D Louis, Kelly L Sullivan, Martin Menkin, Peter B Dunne, Robert A Hauser

Affiliation

¹ Parkinson's Disease and Movement Disorders Center, University of South Florida, Tampa, Florida, USA. tzesiewi@hsc.usf.edu

PMID: 15390069
DOI: 10.1002/mds.20233

Abstract

We report on a woman with idiopathic Meige's syndrome whose dystonia improved with the use of levetiracetam (LEV, Keppra, UCB Pharma, Smyrna, GA). This report and data from an animal model of paroxysmal dystonia suggest that LEV might be helpful in the treatment of dystonia.

2004 Movement Disorder Society.

Publication types

Case Reports

MeSH terms

Anticonvulsants / therapeutic use*
Female
Humans
Levetiracetam
Meige Syndrome / diagnosis
Meige Syndrome / drug therapy*
Meige Syndrome / physiopathology
Middle Aged
Piracetam / analogs & derivatives*
Piracetam / therapeutic use*
Severity of Illness Index
Treatment Outcome

Substances

Anticonvulsants
Levetiracetam
Piracetam